ArticleCMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne2024
Projected estimates of cancer in Canada in 2024.
Erratum issuedAbstract read
In one paragraph
Article in CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 95 papers, 1 of them a synthesis that pooled it.
0numbers the graph read from it
0cells of the map it votes in
95citing papers in PubMed, 1 pooled it
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
95 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Guidance for Canadian Breast Cancer Practice: National Consensus Recommendations for the Systemic Treatment of Patients with HR+/HER2- Early Breast Cancer 2025.Current oncology (Toronto, Ont.) · 2026Guideline
- The Colorectal Cancer Chemoprevention Acceleration and Improvement Platform (CRC-CHAMP) - Cohort Description.Cancer control : journal of the Moffitt Cancer CenterTrial
- Assessing Quality Gaps and Clinician Perspectives on AI Integration in Colorectal Cancer NGS Pathways.Current oncology (Toronto, Ont.) · 2026Article
- A comparison of contrast-to-noise ratio of liver tumors between dynamic contrast-enhanced CT and respiration-tracked 4D-CT for radiotherapy targeting.The British journal of radiology · 2026Article
- Nurses' Perspectives on Cancer Care for People Who Experience Incarceration in British Columbia, Canada: Challenges and Opportunities.The Canadian journal of nursing research = Revue canadienne de recherche en sciences infirmieres · 2026Article
- Optimizing the integration of family physicians into cancer survivorship care in the BC Interior: a mixed methods study of physicians' opinions and experiences.Journal of cancer survivorship : research and practice · 2026Article
- Testing key pathways of the multi-process action control framework: factors associated with exercise identity in people living with and beyond cancer.Journal of behavioral medicine · 2026Article
- Body Composition and Melanoma Outcomes in Patients on Immunotherapy or Targeted Therapy: An Analysis from Canadian Melanoma Research Network.Current oncology (Toronto, Ont.) · 2026Article
- Uncertainty quantification of U-Net based segmentation tool using conformal prediction.Journal of applied clinical medical physics · 2026Article
- Fusion of Clinical and Deep Learning Features for Predicting Pembrolizumab Monotherapy Response in Advanced Non-Small Cell Lung Cancer.Journal of clinical medicine · 2026Article
- Participants' Evolving Experiences, Hope, and Coping While Enrolled in a Community-Based Bereavement Support Program: A Pre-Post Mixed-Methods Pilot Study.Current oncology (Toronto, Ont.) · 2026Article
- Choice and Death: Analysis of Medical Assistance in Dying for Head and Neck Cancer in Ontario.The Laryngoscope · 2026Article
- Public sunscreen dispensers and sun-protective behaviours: an observational study in Toronto, Canada.Preventive medicine reports · 2026Article
- Enhancing the OncoSim-Breast model using Canadian breast density information.Health reports · 2026Article
- The global epidemiology of hepatocellular carcinoma.Hepatology communications · 2026Review
- Guidance for Canadian Breast Cancer Practice: National Consensus Recommendations for the Systemic Treatment of Patients with Triple Negative Breast Cancer in Both the Early and Metastatic Setting 2025.Current oncology (Toronto, Ont.) · 2026Article
- ANGPTL3, Apo CIII, Leptin and Triglycerides Are Elevated in Metastatic Prostate Cancer.Cancers · 2026Article
- The broad societal value of pembrolizumab for women's cancer in Canada.Future oncology (London, England) · 2026Article
- Should we screen for colorectal cancer with biennial FIT beginning at age 45 in Canada?Journal of the Canadian Association of Gastroenterology · 2026Article
- Colon cancer screening at age 45: the time is now.Journal of the Canadian Association of Gastroenterology · 2026Article
35 more citing papers are in PubMed but not listed here.
Corrections and comments
- Erratum issued
Authors and funding
14 authors.
Darren R BrennerDepartments of Oncology and Community Health Sciences (Brenner), Cumming School of Medicine, University of Calgary, Calgary, Alta.; Surveillance, Canadian Cancer Society (Gillis), Vancouver, BC; Centre for Surveillance and Applied Research (Demers), Public Health Agency of Canada; Centre for Population Health Data (Ellison, Billette, Zhang, Liu), Statistics Canada, Ottawa, Ont.; Population Oncology, BC Cancer (Woods), Vancouver, BC; Department of Surgery (Finley), McMaster University and St. Joseph's Health Care Centre, Hamilton, Ont.; System Performance & Analytics (Fitzgerald), Canadian Partnership Against Cancer, Toronto, Ont.; Nova Scotia Health Cancer Care Program (Saint-Jacques), Halifax, NS; Cancer Advanced Analytics (Shack), Cancer Care Alberta, Calgary, Alta; Department of Community Health Sciences (Turner), Max Rady College of Medicine, University of Manitoba; Paul Albrechtsen Research Institute (Turner), CancerCare Manitoba, Winnipeg, Man. Darren.Brenner@ucalgary.ca.
Jennifer GillisDepartments of Oncology and Community Health Sciences (Brenner), Cumming School of Medicine, University of Calgary, Calgary, Alta.; Surveillance, Canadian Cancer Society (Gillis), Vancouver, BC; Centre for Surveillance and Applied Research (Demers), Public Health Agency of Canada; Centre for Population Health Data (Ellison, Billette, Zhang, Liu), Statistics Canada, Ottawa, Ont.; Population Oncology, BC Cancer (Woods), Vancouver, BC; Department of Surgery (Finley), McMaster University and St. Joseph's Health Care Centre, Hamilton, Ont.; System Performance & Analytics (Fitzgerald), Canadian Partnership Against Cancer, Toronto, Ont.; Nova Scotia Health Cancer Care Program (Saint-Jacques), Halifax, NS; Cancer Advanced Analytics (Shack), Cancer Care Alberta, Calgary, Alta; Department of Community Health Sciences (Turner), Max Rady College of Medicine, University of Manitoba; Paul Albrechtsen Research Institute (Turner), CancerCare Manitoba, Winnipeg, Man.
Alain A DemersDepartments of Oncology and Community Health Sciences (Brenner), Cumming School of Medicine, University of Calgary, Calgary, Alta.; Surveillance, Canadian Cancer Society (Gillis), Vancouver, BC; Centre for Surveillance and Applied Research (Demers), Public Health Agency of Canada; Centre for Population Health Data (Ellison, Billette, Zhang, Liu), Statistics Canada, Ottawa, Ont.; Population Oncology, BC Cancer (Woods), Vancouver, BC; Department of Surgery (Finley), McMaster University and St. Joseph's Health Care Centre, Hamilton, Ont.; System Performance & Analytics (Fitzgerald), Canadian Partnership Against Cancer, Toronto, Ont.; Nova Scotia Health Cancer Care Program (Saint-Jacques), Halifax, NS; Cancer Advanced Analytics (Shack), Cancer Care Alberta, Calgary, Alta; Department of Community Health Sciences (Turner), Max Rady College of Medicine, University of Manitoba; Paul Albrechtsen Research Institute (Turner), CancerCare Manitoba, Winnipeg, Man.
Larry F EllisonDepartments of Oncology and Community Health Sciences (Brenner), Cumming School of Medicine, University of Calgary, Calgary, Alta.; Surveillance, Canadian Cancer Society (Gillis), Vancouver, BC; Centre for Surveillance and Applied Research (Demers), Public Health Agency of Canada; Centre for Population Health Data (Ellison, Billette, Zhang, Liu), Statistics Canada, Ottawa, Ont.; Population Oncology, BC Cancer (Woods), Vancouver, BC; Department of Surgery (Finley), McMaster University and St. Joseph's Health Care Centre, Hamilton, Ont.; System Performance & Analytics (Fitzgerald), Canadian Partnership Against Cancer, Toronto, Ont.; Nova Scotia Health Cancer Care Program (Saint-Jacques), Halifax, NS; Cancer Advanced Analytics (Shack), Cancer Care Alberta, Calgary, Alta; Department of Community Health Sciences (Turner), Max Rady College of Medicine, University of Manitoba; Paul Albrechtsen Research Institute (Turner), CancerCare Manitoba, Winnipeg, Man.
Jean-Michel BilletteDepartments of Oncology and Community Health Sciences (Brenner), Cumming School of Medicine, University of Calgary, Calgary, Alta.; Surveillance, Canadian Cancer Society (Gillis), Vancouver, BC; Centre for Surveillance and Applied Research (Demers), Public Health Agency of Canada; Centre for Population Health Data (Ellison, Billette, Zhang, Liu), Statistics Canada, Ottawa, Ont.; Population Oncology, BC Cancer (Woods), Vancouver, BC; Department of Surgery (Finley), McMaster University and St. Joseph's Health Care Centre, Hamilton, Ont.; System Performance & Analytics (Fitzgerald), Canadian Partnership Against Cancer, Toronto, Ont.; Nova Scotia Health Cancer Care Program (Saint-Jacques), Halifax, NS; Cancer Advanced Analytics (Shack), Cancer Care Alberta, Calgary, Alta; Department of Community Health Sciences (Turner), Max Rady College of Medicine, University of Manitoba; Paul Albrechtsen Research Institute (Turner), CancerCare Manitoba, Winnipeg, Man.
Shary Xinyu ZhangDepartments of Oncology and Community Health Sciences (Brenner), Cumming School of Medicine, University of Calgary, Calgary, Alta.; Surveillance, Canadian Cancer Society (Gillis), Vancouver, BC; Centre for Surveillance and Applied Research (Demers), Public Health Agency of Canada; Centre for Population Health Data (Ellison, Billette, Zhang, Liu), Statistics Canada, Ottawa, Ont.; Population Oncology, BC Cancer (Woods), Vancouver, BC; Department of Surgery (Finley), McMaster University and St. Joseph's Health Care Centre, Hamilton, Ont.; System Performance & Analytics (Fitzgerald), Canadian Partnership Against Cancer, Toronto, Ont.; Nova Scotia Health Cancer Care Program (Saint-Jacques), Halifax, NS; Cancer Advanced Analytics (Shack), Cancer Care Alberta, Calgary, Alta; Department of Community Health Sciences (Turner), Max Rady College of Medicine, University of Manitoba; Paul Albrechtsen Research Institute (Turner), CancerCare Manitoba, Winnipeg, Man.
JiaQi Leon LiuDepartments of Oncology and Community Health Sciences (Brenner), Cumming School of Medicine, University of Calgary, Calgary, Alta.; Surveillance, Canadian Cancer Society (Gillis), Vancouver, BC; Centre for Surveillance and Applied Research (Demers), Public Health Agency of Canada; Centre for Population Health Data (Ellison, Billette, Zhang, Liu), Statistics Canada, Ottawa, Ont.; Population Oncology, BC Cancer (Woods), Vancouver, BC; Department of Surgery (Finley), McMaster University and St. Joseph's Health Care Centre, Hamilton, Ont.; System Performance & Analytics (Fitzgerald), Canadian Partnership Against Cancer, Toronto, Ont.; Nova Scotia Health Cancer Care Program (Saint-Jacques), Halifax, NS; Cancer Advanced Analytics (Shack), Cancer Care Alberta, Calgary, Alta; Department of Community Health Sciences (Turner), Max Rady College of Medicine, University of Manitoba; Paul Albrechtsen Research Institute (Turner), CancerCare Manitoba, Winnipeg, Man.
Ryan R WoodsDepartments of Oncology and Community Health Sciences (Brenner), Cumming School of Medicine, University of Calgary, Calgary, Alta.; Surveillance, Canadian Cancer Society (Gillis), Vancouver, BC; Centre for Surveillance and Applied Research (Demers), Public Health Agency of Canada; Centre for Population Health Data (Ellison, Billette, Zhang, Liu), Statistics Canada, Ottawa, Ont.; Population Oncology, BC Cancer (Woods), Vancouver, BC; Department of Surgery (Finley), McMaster University and St. Joseph's Health Care Centre, Hamilton, Ont.; System Performance & Analytics (Fitzgerald), Canadian Partnership Against Cancer, Toronto, Ont.; Nova Scotia Health Cancer Care Program (Saint-Jacques), Halifax, NS; Cancer Advanced Analytics (Shack), Cancer Care Alberta, Calgary, Alta; Department of Community Health Sciences (Turner), Max Rady College of Medicine, University of Manitoba; Paul Albrechtsen Research Institute (Turner), CancerCare Manitoba, Winnipeg, Man.
Christian FinleyDepartments of Oncology and Community Health Sciences (Brenner), Cumming School of Medicine, University of Calgary, Calgary, Alta.; Surveillance, Canadian Cancer Society (Gillis), Vancouver, BC; Centre for Surveillance and Applied Research (Demers), Public Health Agency of Canada; Centre for Population Health Data (Ellison, Billette, Zhang, Liu), Statistics Canada, Ottawa, Ont.; Population Oncology, BC Cancer (Woods), Vancouver, BC; Department of Surgery (Finley), McMaster University and St. Joseph's Health Care Centre, Hamilton, Ont.; System Performance & Analytics (Fitzgerald), Canadian Partnership Against Cancer, Toronto, Ont.; Nova Scotia Health Cancer Care Program (Saint-Jacques), Halifax, NS; Cancer Advanced Analytics (Shack), Cancer Care Alberta, Calgary, Alta; Department of Community Health Sciences (Turner), Max Rady College of Medicine, University of Manitoba; Paul Albrechtsen Research Institute (Turner), CancerCare Manitoba, Winnipeg, Man.
Natalie FitzgeraldDepartments of Oncology and Community Health Sciences (Brenner), Cumming School of Medicine, University of Calgary, Calgary, Alta.; Surveillance, Canadian Cancer Society (Gillis), Vancouver, BC; Centre for Surveillance and Applied Research (Demers), Public Health Agency of Canada; Centre for Population Health Data (Ellison, Billette, Zhang, Liu), Statistics Canada, Ottawa, Ont.; Population Oncology, BC Cancer (Woods), Vancouver, BC; Department of Surgery (Finley), McMaster University and St. Joseph's Health Care Centre, Hamilton, Ont.; System Performance & Analytics (Fitzgerald), Canadian Partnership Against Cancer, Toronto, Ont.; Nova Scotia Health Cancer Care Program (Saint-Jacques), Halifax, NS; Cancer Advanced Analytics (Shack), Cancer Care Alberta, Calgary, Alta; Department of Community Health Sciences (Turner), Max Rady College of Medicine, University of Manitoba; Paul Albrechtsen Research Institute (Turner), CancerCare Manitoba, Winnipeg, Man.
Nathalie Saint-JacquesDepartments of Oncology and Community Health Sciences (Brenner), Cumming School of Medicine, University of Calgary, Calgary, Alta.; Surveillance, Canadian Cancer Society (Gillis), Vancouver, BC; Centre for Surveillance and Applied Research (Demers), Public Health Agency of Canada; Centre for Population Health Data (Ellison, Billette, Zhang, Liu), Statistics Canada, Ottawa, Ont.; Population Oncology, BC Cancer (Woods), Vancouver, BC; Department of Surgery (Finley), McMaster University and St. Joseph's Health Care Centre, Hamilton, Ont.; System Performance & Analytics (Fitzgerald), Canadian Partnership Against Cancer, Toronto, Ont.; Nova Scotia Health Cancer Care Program (Saint-Jacques), Halifax, NS; Cancer Advanced Analytics (Shack), Cancer Care Alberta, Calgary, Alta; Department of Community Health Sciences (Turner), Max Rady College of Medicine, University of Manitoba; Paul Albrechtsen Research Institute (Turner), CancerCare Manitoba, Winnipeg, Man.
Lorraine ShackDepartments of Oncology and Community Health Sciences (Brenner), Cumming School of Medicine, University of Calgary, Calgary, Alta.; Surveillance, Canadian Cancer Society (Gillis), Vancouver, BC; Centre for Surveillance and Applied Research (Demers), Public Health Agency of Canada; Centre for Population Health Data (Ellison, Billette, Zhang, Liu), Statistics Canada, Ottawa, Ont.; Population Oncology, BC Cancer (Woods), Vancouver, BC; Department of Surgery (Finley), McMaster University and St. Joseph's Health Care Centre, Hamilton, Ont.; System Performance & Analytics (Fitzgerald), Canadian Partnership Against Cancer, Toronto, Ont.; Nova Scotia Health Cancer Care Program (Saint-Jacques), Halifax, NS; Cancer Advanced Analytics (Shack), Cancer Care Alberta, Calgary, Alta; Department of Community Health Sciences (Turner), Max Rady College of Medicine, University of Manitoba; Paul Albrechtsen Research Institute (Turner), CancerCare Manitoba, Winnipeg, Man.
Donna TurnerDepartments of Oncology and Community Health Sciences (Brenner), Cumming School of Medicine, University of Calgary, Calgary, Alta.; Surveillance, Canadian Cancer Society (Gillis), Vancouver, BC; Centre for Surveillance and Applied Research (Demers), Public Health Agency of Canada; Centre for Population Health Data (Ellison, Billette, Zhang, Liu), Statistics Canada, Ottawa, Ont.; Population Oncology, BC Cancer (Woods), Vancouver, BC; Department of Surgery (Finley), McMaster University and St. Joseph's Health Care Centre, Hamilton, Ont.; System Performance & Analytics (Fitzgerald), Canadian Partnership Against Cancer, Toronto, Ont.; Nova Scotia Health Cancer Care Program (Saint-Jacques), Halifax, NS; Cancer Advanced Analytics (Shack), Cancer Care Alberta, Calgary, Alta; Department of Community Health Sciences (Turner), Max Rady College of Medicine, University of Manitoba; Paul Albrechtsen Research Institute (Turner), CancerCare Manitoba, Winnipeg, Man.
Canadian Cancer Statistics Advisory Committee
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCancer surveillance data are essential to help understand where gaps exist and progress is being made in cancer control. We sought to summarize the expected impact of cancer in Canada in 2024, with projections of new cancer cases and deaths from cancer by sex and province or territory for all ages combined.
methodsWe obtained data on new cancer cases (i.e., incidence, 1984-2019) and deaths from cancer (i.e., mortality, 1984-2020) from the Canadian Cancer Registry and Canadian Vital Statistics Death Database, respectively. We projected cancer incidence and mortality counts and rates to 2024 for 23 types of cancer, overall, by sex, and by province or territory. We calculated age-standardized rates using data from the 2011 Canadian standard population.
resultsIn 2024, the number of new cancer cases and deaths from cancer are expected to reach 247 100 and 88 100, respectively. The age-standardized incidence rate (ASIR) and mortality rate (ASMR) are projected to decrease slightly from previous years for both males and females, with higher rates among males (ASIR 562.2 per 100 000 and ASMR 209.6 per 100 000 among males; ASIR 495.9 per 100 000 and ASMR 152.8 per 100 000 among females). The ASIRs and ASMRs of several common cancers are projected to continue to decrease (i.e., lung, colorectal, and prostate cancer), while those of several others are projected to increase (i.e., liver and intrahepatic bile duct cancer, kidney cancer, melanoma, and non-Hodgkin lymphoma).
interpretationAlthough the overall incidence of cancer and associated mortality are declining, new cases and deaths in Canada are expected to increase in 2024, largely because of the growing and aging population. Efforts in prevention, screening, and treatment have reduced the impact of some cancers, but these short-term projections highlight the potential effect of cancer on people and health care systems in Canada.
Indexed as
NeoplasmsRegistriesAdultAgedAge DistributionCanadaFemaleForecastingHumansIncidenceMaleMiddle AgedMortalitySex Distribution
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.